APA (7th ed.) Citation

XQ, H., WH, L., CC, Y., LY, L., CH, C., HK, Y., . . . OQ, G. (2026). Is Dose Reduction After Initial Treatment With Denosumab Associated With Subsequent Skeletal-related Events, Osteonecrosis of the Jaw, or Osteoporotic Fractures in Patients With Metastatic Carcinoma? A Nationwide Retrospective Comparative Study. Clinical orthopaedics and related research. https://doi.org/10.1097/CORR.0000000000004052

Chicago Style (17th ed.) Citation

XQ, Heng, et al. "Is Dose Reduction After Initial Treatment With Denosumab Associated With Subsequent Skeletal-related Events, Osteonecrosis of the Jaw, or Osteoporotic Fractures in Patients With Metastatic Carcinoma? A Nationwide Retrospective Comparative Study." Clinical Orthopaedics and Related Research 2026. https://doi.org/10.1097/CORR.0000000000004052.

MLA (9th ed.) Citation

XQ, Heng, et al. "Is Dose Reduction After Initial Treatment With Denosumab Associated With Subsequent Skeletal-related Events, Osteonecrosis of the Jaw, or Osteoporotic Fractures in Patients With Metastatic Carcinoma? A Nationwide Retrospective Comparative Study." Clinical Orthopaedics and Related Research, 2026, https://doi.org/10.1097/CORR.0000000000004052.